Conformis Moves Headquarters to Expanded Facilities in Burlington, MA
BURLINGTON, MA, USA – August 30, 2007 – Conformis, a privately held medical device company dedicated to developing and marketing patient-specific orthopedic implants, today announced completion of its move to a new 15,000 sq. foot headquarter facility in Burlington, MA.
The new facility was chosen to accommodate Conformis’ rapid growth and marks the completion of the management team’s efforts to move commercial operations to Massachusetts. The Burlington headquarter office combines operational functions that previously resided in Foster City, CA and Lexington, MA, including customer service, imaging services, and implant design. The facility will also allow Conformis to bring additional capabilities online in one location, such as manufacturing, rapid prototyping, product sterilization, packaging and shipping, and implant engineering and development.
“Our new headquarters will allow us to scale our operations to better support the rapid growth we have experienced over the last year and expect to see over the foreseeable future,” said Patrick Hess, CEO of Conformis. “Not only will it accommodate the ongoing expansion of key company functions, it also gives us the ability to bring in new infrastructure that was not possible at our previous facilities.”
The new offices are located at 2 Fourth Avenue, Burlington, MA 01803. The company’s telephone numbers, including those for Imaging Services and Customer Service remain the same.
About Conformis, Inc.
Conformis is a privately held medical device company whose mission is to provide best-in-class, minimally invasive implants for orthopedics and sports medicine through the use of its proprietary iFit Technology™. The iFit Technology is a patent-protected, software-enabled process for converting CT and MR imaging data into personalized, patient-specific implants. This ‘image-to-implant’ technology allows for precisely sized and shaped implants that reduce or eliminate the need for cartilage or bone resection and radically simplify the surgical procedure. To date, the company has applied this technology to the knee joint and developed a comprehensive line of knee implants for all stages of osteoarthritis. For more information please visit www.conformis.com.
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards